GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors

By sjmartinez • September 1, 2024

Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors. JACC Heart Fail. 2024 Aug 16:S2213-1779(24)00561-4. doi: 10.1016/j.jchf.2024.07.006. Epub ahead of print. PMID: 39207323.

Tags: Cardiology/Epi, GLP-1 receptor agonists, Heart failure with preserved ejection fraction, Obesity, overweight, Publications, SGLT2is

The noncanonical NFκB pathway: Regulatory mechanisms in health and disease

Rodriguez BN, Huang H, Chia JJ, Hoffmann A. The noncanonical NFκB pathway: Regulatory mechanisms in health and disease. WIREs Mech Dis. 2024 Nov-Dec;16(6):e1646. doi: 10.1002/wsbm.1646.[...]

Acute Coronary Syndrome in Women

Cader FA, Sareen N, Press MC. Acute Coronary Syndrome in Women. Interv Cardiol Clin. 2025 Jan;14(1):9-19. doi: 10.1016/j.iccl.2024.08.011. PMID: 39537292.

The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease

Moore JP, Shivkumar K. The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease. J Am Coll Cardiol. 2024 Nov 19;84(21):2113-2115. doi: 10.1016/j.jacc.2024.08.078. PMID:[...]